LEXX -- Biotech play trading below just closed $5.25 financing$13.2M mkt cap, 3.5M float. Freshly uplisted to NASDAQ. Closed $11M oversubscribed financing at $5.25 on January 14th and trading at discount at $4.40. Oversold on the daily (RSI @ 28). Accum/Dist is evening out after 3 days of selloff. Gap at 6.41. Cash + assets exceed current market cap.
Covid19stock
GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine DevelopmentGeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development
announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company a Small Business Innovative Research (SBIR) grant in support of its development of a vaccine against SARS-CoV-2, the virus that causes COVID-19.
The Phase 1 grant, titled, “Preclinical Development of GV-MVA-VLP Vaccines Against COVID-19,” will support the ongoing design, construction and preclinical testing of GeoVax’s vaccine candidates in preparation for human clinical trials. The efficacy testing will be performed in collaboration with the University of Texas Medical Branch (UTMB).
Vaccines using the GV-MVA-VLP platform developed for other pathogens have proven to be efficacious with a single dose, having strong durability which would be a significant advantage for SARS-CoV-2 global vaccination campaigns.”
We are pleased to receive this Phase 1 SBIR funding award, which will supplement the internal resources allocated to our COVID-19 vaccine program and accelerate our progress toward human clinical trials.
finance.yahoo.com
Has Zoom Lost its Zip?If any stock defined the age of Covid, it would be Zoom Video Communications. Now the videoconferencing disrupter could be showing that sentiment has truly moved on.
ZM has steadily trended lower since peaking near $590 on October 19. It fell on the November 9 vaccine news, and again December 1 -- despite a very strong quarterly report the night before.
ZM is now clinging to an early-September support level around $350. It could be a make-or-break level, with risk of further selling if it fails.
TradeStation data showed that call volume is down by about half since early December. (From about 147,000 calls per day to just 73,000.) That’s another sign of interest waning in the name.
Finally, valuations remain abnormally high -- even after its 40 percent drop. ZM's price/earnings is about 230 times and price/sales is more than 50 to 1.
(This chart features our Smart Relative Strength custom script.)
TradeStation is a pioneer in the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more.
MRNA Moderna Hello receive a cordial greeting, and a thriving 2021 our wishes are that 2021 will be a fantastic year in all aspects for all people.
We believe that this action has a great bullish journey based on Technical and Fundamental Analysis
In the short term adjust your stops as it remains in a bearish structure, butv for the medium term has good bullish goals.
Greetings and best wishes for 2021 L.E.D
In Spain as of 12/31/2020
AMZNHello receive a cordial greeting, and a thriving 2021 our wishes are that 2021 will be a fantastic year in all aspects for all people.
A business that behaved very well in 2020, online sales, this amazon case. And everything related to home service online entertainment...
Amazon
supports: 3099 , 2965
Resistors: 3360 ,3491 ,3541
Sincerely L.E.D. In Spain at 30/12/2020
Amazon AMZNHello receive a cordial greeting, and a thriving 2021 our wishes are that 2021 will be a fantastic year in all aspects for all people.
A business that behaved very well in 2020, online sales, this amazon case. And everything related to home service online entertainment...
Amazon
supports: 3099 , 2965
Resistors: 3360 ,3491 ,3541
Sincerely L.E.D. In Spain at 30/12/2020
US500 S&P500 SPY Bull market 15 MINS TODAY, important tomorrow ; SUPPORT 3725
FOR LIGHT MORNING CORRECTION AND RISE TOUCHING RESISTANCE 3737
Hello, can you help me?
I started to worry about the world of trading in January 2020 and shortly after when the pandemic started and we were confined it was a very useful and interesting hobby. Since the pandemic began and with the confinement, I took courses on the stock market, I read, searched, informed, understood and learned a lot.
MANY have earned with platforms like Robinhood ... big amounts of money and that's great but watch out, don't underestimate financial intelligence.
From May 2020 until today I have published 65 investment ideas and before this shitty year is over I will reach 100
Thank you for your time share and support
L.E.D SPAIN 29/12/2020
US500 Bull market 1H
Hello, can you help me?
I started to worry about the world of trading in January 2020 and shortly after when the pandemic started and we were confined it was a very useful and interesting hobby. Since the pandemic began and with the confinement, I took courses on the stock market, I read, searched, informed, understood and learned a lot.
MANY have earned with platforms like Robinhood ... big amounts of money and that's great but watch out, don't underestimate financial intelligence.
From May 2020 until today I have published 65 investment ideas and before this shitty year is over I will reach 100
Thank you for your time share and support
L.E.D SPAIN 29/12/2020
US500 S&P500 Bull market Hello, can you help me?
I started to worry about the world of trading in January 2020 and shortly after when the pandemic started and we were confined it was a very useful and interesting hobby. Since the pandemic began and with the confinement, I took courses on the stock market, I read, searched, informed, understood and learned a lot.
MANY have earned with platforms like Robinhood ... big amounts of money and that's great but watch out, don't underestimate financial intelligence.
From May 2020 until today I have published 65 investment ideas and before this shitty year is over I will reach 100
Thank you for your time share and support
L.E.D SPAIN 29/12/2020
PEIX vs Ethanol Futures (Chicago)Pacific Ethanol doing a reversal up with COVID spike and Ethanol Futures change. Awaiting this going to target $10-11 on short term with another positive earnings and 3rd plant running more to market need. Announcement also selling into more profitable libations market of low calorie seltzers and other consumer driven markets of STAY AT HOME during COVID-19.
Second Wave of Covid-19If there is an second Virus, which is an diffrent variant of Covid-19, then we will see an drop down to 11000 points for sure.
All the Vaccine hype will be over.
Stay safe!
If not, we will have an stop near to us, but if the yellow line will broke it will go down to the next green line, if this can´t hold drop to the next and so on.
KNR.C -- Inverse Head & Shoulders Breakout!Classic Inverse Head & Shoulders breakout on good volume. 4.16 about to get filled and likely $5+ coming before the week's end. Promo campaign is under way and news of sales and/or uplisting to TSX/NASDAQ is expected.
Power Up WorldWith the Vaccine soon to be Online this Chart is looking Fantastic. Covid Has put a Hurting on mines and production is gonna be in Full demand The worlds Power plant are in Great need Uranium.
So with some Volume Short term and long term Macro Chart Look like they are Warming up double Bottom cup Formation Handel to Lift off like to enter somewhere near 12.60 on volume
MRNA Blow Off Top ConfirmedMRNA broke out of $100 hitting $178 within 4 days on high volume and multiple gap ups. This is significant evidence of a blow off top. Afterwards, we printed a daily bullish engulfing pattern then corrected upwards for 5 days before printing another daily engulfing pattern. The target is $100, which completes the blow off top move and the 1.618 extension of the Wave A move. Blow off tops have sharp moves and just as sharp reversals. I'd expect to see $100 by next week.
Vaccibody $VACC leaping to ATH after releasing #Covid19 Data Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy
● Vaccibody demonstrates promising pre-clinical data with its second-generation COVID-19 vaccine candidate, VB10.COV2
● VB10.COV2 induces rapid, strong and long-lasting neutralizing antibodies and multifunctional, dominant CD8+ T cell and Th1 CD4+ T cell responses in mice after a single dose
● Vaccibody will present the pre-clinical data and its broader infectious disease strategy during a webcast on Friday December 11 at 10 am CET